rs121917810

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_000686.5(AGTR2):​c.62G>T​(p.Gly21Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,208,856 control chromosomes in the GnomAD database, including 13 homozygotes. There are 1,581 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G21R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 2 hom., 76 hem., cov: 23)
Exomes 𝑓: 0.0042 ( 11 hom. 1505 hem. )

Consequence

AGTR2
NM_000686.5 missense

Scores

2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:6

Conservation

PhyloP100: 0.485

Publications

10 publications found
Variant links:
Genes affected
AGTR2 (HGNC:338): (angiotensin II receptor type 2) The protein encoded by this gene belongs to the G-protein coupled receptor 1 family, and functions as a receptor for angiotensin II. It is an intergral membrane protein that is highly expressed in fetus and in neonates, but scantily in adult tissues, except brain, adrenal medulla, and atretic ovary. This receptor has been shown to mediate programmed cell death and this apoptotic function may play an important role in developmental biology and pathophysiology. Mutations in this gene are been associated with X-linked cognitive disability. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and SARS-CoV-2 infection results in down-regulation of angiotensin converting enzyme-2 (ACE2) receptors, the effects of which, triggers serious inflammatory lesions in the tissues involved, primarily in the lungs. The inflammatory reaction appears to be mediated by angiotensin II derivatives, including the angiotensin AT2 receptor which has been found to be upregulated in bronchoalveolar lavage samples from Coronavirus disease 2019 (COVID19) patients. [provided by RefSeq, Jul 2020]
AGTR2 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0701001).
BP6
Variant X-116172342-G-T is Benign according to our data. Variant chrX-116172342-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 11716.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000686.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGTR2
NM_000686.5
MANE Select
c.62G>Tp.Gly21Val
missense
Exon 3 of 3NP_000677.2
AGTR2
NM_001385624.1
c.62G>Tp.Gly21Val
missense
Exon 2 of 2NP_001372553.1P50052

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGTR2
ENST00000371906.5
TSL:1 MANE Select
c.62G>Tp.Gly21Val
missense
Exon 3 of 3ENSP00000360973.4P50052
AGTR2
ENST00000681852.1
c.62G>Tp.Gly21Val
missense
Exon 2 of 2ENSP00000505750.1P50052
AGTR2
ENST00000971224.1
c.62G>Tp.Gly21Val
missense
Exon 3 of 3ENSP00000641283.1

Frequencies

GnomAD3 genomes
AF:
0.00273
AC:
304
AN:
111214
Hom.:
2
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000426
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00335
Gnomad ASJ
AF:
0.00114
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00188
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00837
Gnomad NFE
AF:
0.00453
Gnomad OTH
AF:
0.00401
GnomAD2 exomes
AF:
0.00251
AC:
459
AN:
183135
AF XY:
0.00253
show subpopulations
Gnomad AFR exome
AF:
0.000532
Gnomad AMR exome
AF:
0.00256
Gnomad ASJ exome
AF:
0.00147
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.00410
Gnomad OTH exome
AF:
0.00133
GnomAD4 exome
AF:
0.00417
AC:
4576
AN:
1097590
Hom.:
11
Cov.:
31
AF XY:
0.00414
AC XY:
1505
AN XY:
363134
show subpopulations
African (AFR)
AF:
0.000531
AC:
14
AN:
26375
American (AMR)
AF:
0.00256
AC:
90
AN:
35140
Ashkenazi Jewish (ASJ)
AF:
0.000878
AC:
17
AN:
19360
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30193
South Asian (SAS)
AF:
0.00170
AC:
92
AN:
54136
European-Finnish (FIN)
AF:
0.000123
AC:
5
AN:
40519
Middle Eastern (MID)
AF:
0.0104
AC:
43
AN:
4134
European-Non Finnish (NFE)
AF:
0.00490
AC:
4123
AN:
841668
Other (OTH)
AF:
0.00417
AC:
192
AN:
46065
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
174
347
521
694
868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00271
AC:
301
AN:
111266
Hom.:
2
Cov.:
23
AF XY:
0.00227
AC XY:
76
AN XY:
33552
show subpopulations
African (AFR)
AF:
0.000425
AC:
13
AN:
30616
American (AMR)
AF:
0.00335
AC:
35
AN:
10446
Ashkenazi Jewish (ASJ)
AF:
0.00114
AC:
3
AN:
2631
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3535
South Asian (SAS)
AF:
0.00113
AC:
3
AN:
2646
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5967
Middle Eastern (MID)
AF:
0.00917
AC:
2
AN:
218
European-Non Finnish (NFE)
AF:
0.00453
AC:
240
AN:
53009
Other (OTH)
AF:
0.00330
AC:
5
AN:
1515
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00387
Hom.:
204
Bravo
AF:
0.00291
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00588
AC:
17
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.00461
AC:
31
ExAC
AF:
0.00249
AC:
302
EpiCase
AF:
0.00551
EpiControl
AF:
0.00582

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
3
not specified (3)
-
-
1
Intellectual disability, X-linked 88 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
1.7
DANN
Benign
0.44
DEOGEN2
Benign
0.36
T
FATHMM_MKL
Benign
0.093
N
LIST_S2
Benign
0.37
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.070
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.48
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.35
N
REVEL
Uncertain
0.37
Sift
Benign
0.20
T
Sift4G
Benign
0.22
T
Polyphen
0.0
B
Vest4
0.055
MVP
0.85
MPC
0.18
ClinPred
0.0015
T
GERP RS
3.6
Varity_R
0.062
gMVP
0.48
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121917810; hg19: chrX-115303595; API